Skip Navigation
The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients
Search
Home » Advanced Search
Search Results for Selective Serotonin Reuptake Inhibitors (SSRIs)
Perform Another (Advanced) Search
18 Results within Entire Site
Limit results to show: Entire Site Clinical Trial Listings Newly Approved Drugs Research Center Profiles Industry Providers New Medical Results Clinical Trials Today Headlines
1. Study Posting (799) Trial #161750, Depression, Boston, MA ...Study Posting (799) Trial #161750, Depression, Boston, MA combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI)<br/>Escitalopram for patients with Major Depressive Disorder (MDD) that do not ...View Page
2. Study Posting (799) Trial #159744, Depression, Boston, MA ...Study Posting (799) Trial #159744, Depression, Boston, MA combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI)<br/>Escitalopram for patients with Major Depressive Disorder (MDD) that do not ...View Page
3. Study Posting (799) Trial #156617, Depression, Boston, MA ...Study Posting (799) Trial #156617, Depression, Boston, MA combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI)<br/>Escitalopram for patients with Major Depressive Disorder (MDD) that do not ...View Page
4. Study Posting (799) Trial #161751, Depression (Treatment-Resistant), Boston, MA ...Study Posting (799) Trial #161751, Depression (Treatment-Resistant), Boston, MA combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI)<br/>Escitalopram for patients with Major Depressive Disorder (MDD) that do not ...View Page
5. Study Posting (799) Trial #161733, Depression (Major/Severe), Boston, MA ...Study Posting (799) Trial #161733, Depression (Major/Severe), Boston, MA combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI)<br/>Escitalopram for patients with Major Depressive Disorder (MDD) that do not ...View Page
6. Study Posting (799) Trial #159734, Depression (Major/Severe), Boston, MA ...Study Posting (799) Trial #159734, Depression (Major/Severe), Boston, MA combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI)<br/>Escitalopram for patients with Major Depressive Disorder (MDD) that do not ...View Page
7. Study Posting (799) Trial #156606, *Healthy Patient Studies, Boston, MA ...Study Posting (799) Trial #156606, *Healthy Patient Studies, Boston, MA combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI)<br/>Escitalopram for patients with Major Depressive Disorder (MDD) that do not ...View Page
8. Study Posting (709) Trial #116328, Depression, Stanford, CA ...research is to get information on the effectiveness of switching to duloxetine (Cymbalta) from a selective serotonin reuptake inhibitor (SSRI) to relieve sexual dysfunction in patients with depression. Duloxetine has been approved ...View Page
9. Study Posting (709) Trial #116327, Sexual Dysfunction, Stanford, CA ...research is to get information on the effectiveness of switching to duloxetine (Cymbalta) from a selective serotonin reuptake inhibitor (SSRI) to relieve sexual dysfunction in patients with depression. Duloxetine has been approved ...View Page
10. CenterWatch: Clinical Trials in Category (46) Depression (Treatment-Resistant) ...designed to test the efficacy, tolerability and safety of the combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI) Escitalopram for patients with Major Depressive Disorder (MDD) that do not sufficiently ...View Page
11. Study Posting (2829) Trial #155112, Depression, San Antonio, TX ...MDD), who were identified as partial responders to an adequate course of treatment with a selective serotonin reuptake inhibitor (SSRI) (as defined by history). Inclusion Criteria: • Meet criteria for MDD as defined ...View Page
12. Newly Approved Drug Therapies (104) Paxil (paroxetine hydrochloride), SmithKline Beecham, ...at some time in their lives. Paxil belongs to a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). For many years, the only drug indicated for panic disorder was the ...View Page
13. Study Posting (1918) Trial #159850, Prostate Cancer, Savannah, GA ...THERAPY : • See Disease Characteristics • More than 14 days since prior venlafaxine, monoamine oxidase inhibitor (MAOI), selective serotonin reuptake inhibitor (SSRI), or selective norepinephrine reuptake inhibitor (SNRI) • No concurrent chemotherapy, radiotherapy, or surgery ...View Page
14. Study Posting (1918) Trial #159849, Hot Flash, Savannah, GA ...THERAPY : • See Disease Characteristics • More than 14 days since prior venlafaxine, monoamine oxidase inhibitor (MAOI), selective serotonin reuptake inhibitor (SSRI), or selective norepinephrine reuptake inhibitor (SNRI) • No concurrent chemotherapy, radiotherapy, or surgery ...View Page
15. CenterWatch Clinical Research Profile (799) Trial #350, Massachusetts General Hospital, Boston, MA ...designed to test the efficacy, tolerability and safety of the combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI) Escitalopram for patients with Major Depressive Disorder (MDD) that do not sufficiently ...View Page
16. Study Posting (4265) Trial #163387, Alcohol Dependence, West Palm Beach, FL ...Current need for antidepressants including, but not limited to, monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs), and/or lithium Miriam Trelka, Clinical Research Coordinator Janus Center for Psychiatric ...View Page
17. CenterWatch: Clinical Trials in Category (97) Depression (Major/Severe) ...designed to test the efficacy, tolerability and safety of the combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI) Escitalopram for patients with Major Depressive Disorder (MDD) that do not sufficiently ...View Page
18. CenterWatch: Clinical Trials in Category (164) Depression ...designed to test the efficacy, tolerability and safety of the combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI) Escitalopram for patients with Major Depressive Disorder (MDD) that do not sufficiently ...View Page
Copyright © 2008 Jobson Medical Information LLC.
Designed by Piehead Productions LLC.